iBio Inc (IBIO): Buying 1,44 :)

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

iBio Inc (IBIO)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	72
Posts	9917
Boards Moderated	0
Alias Born	09/05/2009

Re: None

Thursday, 10/23/2014 10:19:01 AM

Thursday, October 23, 2014 10:19:01 AM

Buying 1,44 :)

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IBIO News

Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:24:33 PM
iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development • GlobeNewswire Inc. • 08/12/2024 08:30:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/06/2024 09:02:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 01:03:41 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 09:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM

More IBIO News

InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow